In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Kathryn ByerlyDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0001-9894-4496 Cayla WolfeDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Magdalena BreiDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0009-0001-3045-4025 Hannah ParrisDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Savannah FisherDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Aimee AlstonDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Hanmei DongClemson-MUSC Bioengineering Program, Department of Bioengineering, Clemson University, Charleston, SC 29425, USA.ORCID 0000-0001-8374-8513 Peng ChenClemson-MUSC Bioengineering Program, Department of Bioengineering, Clemson University, Charleston, SC 29425, USA.ORCID 0000-0002-3883-4671 Hai YaoClemson-MUSC Bioengineering Program, Department of Bioengineering, Clemson University, Charleston, SC 29425, USA.ORCID 0000-0001-5130-5128 Fulei TangDepartment of Comparative Medicine, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0003-2102-1137 Jan GuzDepartment of Comparative Medicine, Medical University of South Carolina, Charleston, SC 29407, USA.
Sarah DooleyDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0001-7229-0148 Taylor NelsonDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0003-1524-5804 Brian LoizziDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0009-0008-5912-0329 Ranan PhookanDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0009-0005-0625-2449 Cortney GensemerDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0002-8492-3536 Sunil PatelDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC 29407, USA.
Russell A NorrisDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0001-8462-5726 Funding
Tissue Structural and Neural Remodeling in Human Sacroiliac JointP20GM121342 · NIGMS · CLEMSON UNIVERSITY · PI Jeryl Jones · 2018 to 2026
$24.7MAmerican Heart Association TPA34850095National Heart Lung and Blood Institute HL131546National Heart Lung and Blood Institute HL149696National Heart Lung and Blood Institute HL173930NIDCR NIH HHS DE021134NIGMS NIH HHS P20 GM121342NIGMS NIH HHS P20GM121342
6 · The paper itselfAbstract
Van Maldergem Syndrome (VMS) is a rare autosomal recessive disorder caused by pathogenic variants in the atypical cadherin genes
Indexed as
CadherinsCraniofacial AbnormalitiesIntellectual DisabilityNeurodevelopmental DisordersNeurogenesisAbnormalities, MultipleAnimalsBrainCell ProliferationFoot Deformities, CongenitalHand Deformities, CongenitalJoint InstabilityMiceNeurodevelopmentNeuronsProtein DomainsCadherinsDchs1 protein, mousecell polarityDachsousheterotopiaHippo signalingneurodevelopment
Identifiers
PMID41972678
PMCPMC13072099
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390